Cargando…
FOXP1-induced lncRNA CLRN1-AS1 acts as a tumor suppressor in pituitary prolactinoma by repressing the autophagy via inactivating Wnt/β-catenin signaling pathway
As the commonest type of functional pituitary tumor, prolactinoma takes up around 40–60% of functional pituitary tumors. Despite dedications attributed to the treatment of prolactinoma, complete cure remains difficult. Hence, it is of significance to bring to light the underlying mechanism of prolac...
Autores principales: | Wang, Chao, Tan, Chunlei, Wen, Yuan, Zhang, Dongzhi, Li, Guofu, Chang, Liang, Su, Jun, Wang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591247/ https://www.ncbi.nlm.nih.gov/pubmed/31235696 http://dx.doi.org/10.1038/s41419-019-1694-y |
Ejemplares similares
-
Disease-causing mutations in the CLRN1 gene alter normal CLRN1 protein trafficking to the plasma membrane
por: Isosomppi, Juha, et al.
Publicado: (2009) -
DICER1 mutation and pituitary prolactinoma
por: Cotton, Ellena, et al.
Publicado: (2018) -
CLRN1 Is Nonessential in the Mouse Retina but Is Required for Cochlear Hair Cell Development
por: Geller, Scott F., et al.
Publicado: (2009) -
LncRNA GASL1 inhibits tumor growth in gastric carcinoma by inactivating the Wnt/β-catenin signaling pathway
por: Peng, Cao, et al.
Publicado: (2019) -
Two novel disease-causing mutations in the CLRN1 gene in patients with Usher syndrome type 3
por: García-García, Gema, et al.
Publicado: (2012)